trending Market Intelligence /marketintelligence/en/news-insights/trending/X5GQu1xa06ZabJg4bBV71g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

SK Capital acquires Perrigo's active pharmaceutical ingredients business

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


SK Capital acquires Perrigo's active pharmaceutical ingredients business

Perrigo Co. plc's active pharmaceutical ingredients business was renamed to Wavelength Pharmaceuticals after U.S. private investment firm SK Capital completed the acquisition.

Wavelength produces generic active pharmaceutical ingredients, with primary operations in Israel and supporting functions in the U.S. and India.

Apollo Global Management and its affiliates along with MidCap Financial provided debt financing for the transaction. RBC Capital Markets LLC and Rothschild acted as SK Capital's joint advisers.